Astex Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 5 of about 5   

Articles published

ASTX 0.0000
price chart
Chancery Won't End Astex Buyout Case, Citing Lack Of Notice
Law360, New York (August 26, 2014, 7:08 PM ET) -- A Delaware Chancery Court judge declined Monday to close a consolidated shareholder class action challenging Astex Pharmaceuticals Inc.'s planned $886 million buyout by Japanese drugmaker Otsuka ...
Related articles »  
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic ...
PISCATAWAY, N.J., Aug. 29, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai ...
Related articles »  
Array BioPharma Reports Financial Results For The Fourth Quarter And Full ...
12, 2014 /PRNewswire/ -- Array BioPharma Inc. ARRY, +2.07% today reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014.
Related articles »  
InnoPharma's decitabine for injection receives US FDA approval for treatment ...
InnoPharma, Inc., a privately held, sterile product development company, announced that its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai Inc.'s Dacogen has received the approval from the US Food and ...
Related articles »  
Biotech Stock Directory Update
Astex Pharmaceuticals, Inc. (NasdaqGS:ASTX ) is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology.